The preclinical studies in cooperation with the University Hospital Vienna are continued in 2023. A new agreement has been signed with the focus on further supporting the VCC-001 development.
The preclinical studies in cooperation with the University Hospital Vienna are continued in 2023. A new agreement has been signed with the focus on further supporting the VCC-001 development.
Vaccentis AG,
Gerechtigkeitsgasse 25, CH - 8001 Zürich